ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-4.37%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$331M
AUM Growth
+$331M
(-10%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-5.34%
Top 10 Holdings %
Top 10 Hldgs %
52.13%
Holding
90
New
22
Increased
20
Reduced
16
Closed
27
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.2M |
| 2 |
Orthofix Medical
OFIX
|
$13.6M |
| 3 |
Centene
CNC
|
$12.4M |
| 4 |
McKesson
MCK
|
$8.93M |
| 5 |
Avantor
AVTR
|
$6.05M |
Top Sells
| 1 |
Sanofi
SNY
|
$21.3M |
| 2 |
Cencora
COR
|
$15.3M |
| 3 |
Dentsply Sirona
XRAY
|
$9.62M |
| 4 |
Becton Dickinson
BDX
|
$8.66M |
| 5 |
SI-BONE Inc
SIBN
|
$7.99M |
Sector Composition
| 1 | Healthcare | 80.72% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
26
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.6M | 0.95% |
120,834
+55,196
| +84% | +$1.65M |
|
27
Galapagos
GLPG
$2.06B
| $3.25M | 0.86% |
+52,400
| New | +$3.25M |
|
28
Idexx Laboratories
IDXX
$50.7B
| $3.13M | 0.83% |
+5,729
| New | +$3.13M |
|
29
Qiagen
QGEN
$10.1B
| $2.73M | 0.72% |
+52,487
| New | +$2.73M |
|
30
Premier
PINC
$2.11B
| $2.69M | 0.71% |
+75,632
| New | +$2.69M |
|
31
Sutro Biopharma
STRO
$85.6M
| $2.44M | 0.64% |
296,508
+184,705
| +165% | +$1.52M |
|
32
Mettler-Toledo International
MTD
$26.1B
| $2.42M | 0.64% |
+1,765
| New | +$2.42M |
|
33
Fate Therapeutics
FATE
$115M
| $2.32M | 0.61% |
59,732
+22,407
| +60% | +$869K |
|
34
Tandem Diabetes Care
TNDM
$834M
| $2.12M | 0.56% |
+18,236
| New | +$2.12M |
|
|
KRTX
35
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.95M | 0.51% |
+15,342
| New | +$1.95M |
|
36
10x Genomics
TXG
$1.66B
| $1.9M | 0.5% |
+24,923
| New | +$1.9M |
|
|
BHVN
37
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.83M | 0.48% |
15,400
+9,331
| +154% | +$1.11M |
|
38
Vertex Pharmaceuticals
VRTX
$102B
| $1.82M | 0.48% |
+6,982
| New | +$1.82M |
|
39
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.7M | 0.45% |
+10,379
| New | +$1.7M |
|
|
AFMD
40
DELISTED
Affimed
AFMD
| $1.55M | 0.41% |
+35,449
| New | +$1.55M |
|
41
Viridian Therapeutics
VRDN
$1.59B
| $1.54M | 0.41% |
83,217
+15,767
| +23% | +$292K |
|
|
GBT
42
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.5M | 0.39% |
43,250
+453
| +1% | +$15.7K |
|
43
Immunic
IMUX
$79.4M
| $1.48M | 0.39% |
130,567
-53,976
| -29% | -$610K |
|
44
argenx
ARGX
$44.2B
| $1.41M | 0.37% |
+4,480
| New | +$1.41M |
|
45
ICU Medical
ICUI
$3.06B
| $1.36M | 0.36% |
6,093
-1,673
| -22% | -$373K |
|
46
Arcus Biosciences
RCUS
$1.24B
| $1.22M | 0.32% |
+38,650
| New | +$1.22M |
|
47
Rhythm Pharmaceuticals
RYTM
$6.75B
| $1.22M | 0.32% |
105,792
-91,670
| -46% | -$1.06M |
|
|
MTEM
48
DELISTED
Molecular Templates, Inc.
MTEM
| $1.08M | 0.29% |
20,949
+3,057
| +17% | +$158K |
|
49
CareDx
CDNA
$678M
| $1.04M | 0.27% |
+28,048
| New | +$1.04M |
|
50
Iovance Biotherapeutics
IOVA
$800M
| $1.01M | 0.27% |
60,720
+6,739
| +12% | +$112K |
|